Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Mar 6;39(3):BSR20190327.
doi: 10.1042/BSR20190327. Print 2019 Mar 29.

Cofactor-mediated amyloidogenesis

Affiliations
Comment

Cofactor-mediated amyloidogenesis

Jillian Madine. Biosci Rep. .

Abstract

A recent study published in Bioscience Reports by Sheng et al. (Bioscience Reports, (2019) 39, pii:BSR20182345] described a small but significant conformational change that occurs upon zinc binding and results in initiation of the amyloidogenic aggregation cascade of Golgi-Associated plant Pathogenesis Related protein 1 (GAPR-1) in the presence of heparin. The present study describes a two-stage process that is required for the initiation of the amyloidogenic aggregation cascade involving a concentration step and a conformation change to enhance accessibility of natively protected amyloidogenic regions for self-association. For GAPR-1 in the present study, these steps are provided by zinc binding causing the required conformational change enhancing accessibility of amyloidogenic regions, and heparin providing a template or scaffold in turn increasing the local protein concentration. Cofactors such as glycosaminoglycans and metal ions have been found associated with amyloid deposits in vivo and shown to affect protein assembly kinetics in vitro. Cofactor interactions with the amyloidogenic process are an area of great interest for therapeutic intervention for the wide range of diseases known to be associated with amyloid protein aggregation. The present study emphasises the need for enhanced structural understanding of cofactor-amyloid protein interactions and highlights that small subtle conformational changes can have large impacts on resulting aggregation processes.

Keywords: amyloid; glycosaminoglycans; membrane-interactions; metal ions; protein aggregation.

PubMed Disclaimer

Conflict of interest statement

The author declares that there are no competing interests associated with the manuscript.

Comment on

  • Zinc binding regulates amyloid-like aggregation of GAPR-1.
    Sheng J, Olrichs NK, Geerts WJ, Li X, Rehman AU, Gadella BM, Kaloyanova DV, Helms JB. Sheng J, et al. Biosci Rep. 2019 Feb 12;39(2):BSR20182345. doi: 10.1042/BSR20182345. Print 2019 Feb 28. Biosci Rep. 2019. PMID: 30700571 Free PMC article.

Similar articles

Cited by

References

    1. Olrichs N.K., Mahalka A.K., Kaloyanova D., Kinnunen P.K. and Bernd Helms J. (2014) Golgi-Associated plant Pathogenesis Related protein 1 (GAPR-1) forms amyloid-like fibrils by interaction with acidic phospholipids and inhibits Aβ aggregation. Amyloid 21, 88–96 10.3109/13506129.2014.882304 - DOI - PubMed
    1. Benson M.D., Buxbaum J.N., Eisenberg D.S., Merlini G., Saraiva M.J.M., Sekijima Y.. et al. (2019) Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid 25, 215–219 10.1080/13506129.2018.1549825 - DOI - PubMed
    1. Lovell M.A., Robertson J.D., Teesdale W.J., Campbell J.L. and Markesbery W.R. (1998) Copper, iron and zinc in Alzheimer’s disease senile plaques. J. Neurol. Sci. 158, 47–52 10.1016/S0022-510X(98)00092-6 - DOI - PubMed
    1. Viles J.H. (2012) Metal ions and amyloid fiber formation in neurodegenerative diseases. Copper, zinc and iron in Alzheimer’s, Parkinson’s and prion diseases. Coordin. Chem. Rev. 256, 2271–2284 10.1016/j.ccr.2012.05.003 - DOI
    1. Sarell C.J., Wilkinson S.R. and Viles J.H. (2010) Substoichiometric levels of Cu2+ ions accelerate the kinetics of fiber formation and promote cell toxicity of amyloid-β from Alzheimer disease. J. Biol. Chem. 285, 41533–41540 10.1074/jbc.M110.171355 - DOI - PMC - PubMed

Publication types